表紙
市場調査レポート

アラブ首長国連邦の神経系医療機器への投資機会:分析と2017年までの予測

United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018

発行 Global Markets Direct 商品コード 199837
出版日 ページ情報 英文 109 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
アラブ首長国連邦の神経系医療機器への投資機会:分析と2017年までの予測 United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018
出版日: 2012年05月28日 ページ情報: 英文 109 Pages
概要

当レポートでは、アラブ首長国連邦における神経系医療機器市場全体の収益とともに、CSF管理、神経インターベンション、神経刺激装置などについて、それそれのセグメント別動向、販売台数、市場に参入する主な企業のプロファイルをまとめ、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

第3章 アラブ首長国連邦における神経系医療機器

  • 総収益:2003〜2017年
  • カテゴリー別の出荷台数:2003〜2017年
  • 企業シェア:2009〜2010年

第4章 アラブ首長国連邦におけるCSF管理

  • 総収益:2003〜2017年
  • 総販売台数:2003〜2017年
  • 平均価格:2003〜2017年
  • 流通シェア:2009〜2010年
  • 企業シェア:2009〜2010年

第5章 アラブ首長国連邦における神経インターベンション

  • 総収益:2003〜2017年
  • 総販売台数:2003〜2017年
  • 平均価格:2003〜2017年
  • 流通シェア:2009〜2010年
  • 企業シェア:2009〜2010年

第6章 アラブ首長国連邦における神経学的診断装置

  • 総収益:2003〜2017年
  • 総販売台数:2003〜2017年
  • 平均価格:2003〜2017年
  • 流通シェア:2009〜2010年
  • 企業シェア:2009〜2010年

第7章 アラブ首長国連邦における神経刺激装置

  • 総収益:2003〜2017年
  • 総販売台数:2003〜2017年
  • 平均価格:2003〜2017年
  • 流通シェア:2009〜2010年
  • 企業シェア:2009〜2010年

第8章 アラブ首長国連邦における神経外科製品

  • 総収益:2003〜2017年
  • 総販売台数:2003〜2017年
  • 平均価格:2003〜2017年
  • 流通シェア:2009〜2010年
  • 企業シェア:2009〜2010年

第9章 主な企業の概要

  • Medtronic, Inc.
  • 日本光電
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • テルモ
  • Natus Medical Incorporated
  • CareFusion Corporation
  • Covidien plc
  • St. Jude Medical, Inc.
  • DePuy, Inc.
  • Integra LifeSciences Holdings Corporation
  • ev3 Inc.
  • Cyberonics, Inc.
  • Micrus Endovascular Corporation
  • KARL STORZ GmbH & Co. KG
  • Sophysa S.A

第10章 付録

図表

目次
Product Code: GMDME0249IDB

Summary

"United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018", a new report by Global Markets Direct, provides key market data on the United Arab Emirates Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.

Scope

  • Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
  • 2011 company shares and distribution shares data for each of the five market categories.
  • Global corporate-level profiles of key companies operating within the United Arab Emirates Neurology Devicesmarket.
  • Key players covered include Medtronic, Inc., Nihon Kohden Corporation, B. Braun Melsungen AG, DePuy, Inc., Stryker Corporation, Integra LifeSciences Holdings Corporation and others.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the United Arab Emirates Neurology Devices competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What is This Report About?

3. Neurology Devices In United Arab Emirates

  • 3.1. Neurology Devices, United Arab Emirates, Overall Revenue ($m), USD Constant, 2004-2018
  • 3.2. Neurology Devices, United Arab Emirates, Company Share (2010-2011)

4. CSF Management In United Arab Emirates

  • 4.1. CSF Management Overall Revenue, (2004-2018)
  • 4.2. CSF Management Overall Volume (2004-2018)
  • 4.3. CSF Management Average Price (2004-2018)
  • 4.4. CSF Management Distribution Share (2010-2011)
  • 4.5. CSF Management, United Arab Emirates, Company Share (2010-2011)

5. Interventional Neurology In United Arab Emirates

  • 5.1. Interventional Neurology Overall Revenue, (2004-2018)
    • 5.1.1. Embolic Systems, Revenue (2004-2018)
    • 5.1.2. Navigational Systems, Revenue (2004-2018)
  • 5.2. Interventional Neurology Overall Volume (2004-2018)
    • 5.2.1. Embolic Systems, Volume (2004-2018)
    • 5.2.2. Navigational Systems, Volume (2004-2018)
  • 5.3. Interventional Neurology Average Price (2004-2018)
  • 5.4. Interventional Neurology Distribution Share (2010-2011)
  • 5.5. Interventional Neurology, United Arab Emirates, Company Share (2010-2011)

6. Neurological Diagnostic Equipment In United Arab Emirates

  • 6.1. Neurological Diagnostic Equipment Overall Revenue, (2004-2018)
  • 6.2. Neurological Diagnostic Equipment Overall Volume (2004-2018)
  • 6.3. Neurological Diagnostic Equipment Average Price (2004-2018)
  • 6.4. Neurological Diagnostic Equipment Distribution Share (2010-2011)
  • 6.5. Neurological Diagnostic Equipment, United Arab Emirates, Company Share (2010-2011)

7. Neurostimulation Devices In United Arab Emirates

  • 7.1. Neurostimulation Devices Overall Revenue, (2004-2018)
  • 7.2. Neurostimulation Devices Overall Volume (2004-2018)
  • 7.3. Neurostimulation Devices Average Price (2004-2018)
  • 7.4. Neurostimulation Devices Distribution Share (2010-2011)
  • 7.5. Neurostimulation Devices, United Arab Emirates, Company Share (2010-2011)

8. Neurosurgical Products In United Arab Emirates

  • 8.1. Neurosurgical Products Overall Revenue, (2004-2018)
  • 8.2. Neurosurgical Products Overall Volume (2004-2018)
  • 8.3. Neurosurgical Products Average Price (2004-2018)
  • 8.4. Neurosurgical Products Distribution Share (2010-2011)
  • 8.5. Neurosurgical Products, United Arab Emirates, Company Share (2010-2011)

9. Overview of Key Companies in United Arab Emirates Neurology Devices Market

  • 9.1. Medtronic, Inc.
    • 9.1.1. Company Overview
  • 9.2. Nihon Kohden Corporation
    • 9.2.1. Company Overview
  • 9.3. B. Braun Melsungen AG
    • 9.3.1. Company Overview
  • 9.4. DePuy, Inc.
    • 9.4.1. Company Overview
  • 9.5. Stryker Corporation
    • 9.5.1. Company Overview
  • 9.6. Integra LifeSciences Holdings Corporation
    • 9.6.1. Company Overview
  • 9.7. Christoph Miethke GmbH & Co. KG
    • 9.7.1. Company Overview
  • 9.8. Natus Medical Incorporated
    • 9.8.1. Company Overview
  • 9.9. CareFusion Corporation
    • 9.9.1. Company Overview
  • 9.10. Covidien plc
    • 9.10.1. Company Overview
  • 9.11. St. Jude Medical, Inc.
    • 9.11.1. Company Overview
  • 9.12. Terumo Corporation
    • 9.12.1. Company Overview
  • 9.13. Sophysa S.A.
    • 9.13.1. Company Overview
  • 9.14. Cyberonics, Inc.
    • 9.14.1. Company Overview
  • 9.15. Boston Scientific Corporation
    • 9.15.1. Company Overview
  • 9.16. KARL STORZ GmbH & Co. KG
    • 9.16.1. Company Overview

10. Appendix

  • 10.1. Global Markets Direct Research Methodology
  • 10.2. Definitions of Markets Covered in the Report
    • 10.2.1. Neurology Devices
  • 10.3. Secondary Research
  • 10.4. Primary Research
  • 10.5. Models
  • 10.6. Forecasts
  • 10.7. Expert Panel Validation
  • 10.8. Currency Conversion
  • 10.9. Contact Us
  • 10.10. Disclaimer

List of Tables

  • Table 1: Neurology Devices, United Arab Emirates, Overall Revenue ($m), USD Constant, 2004-2018
  • Table 2: Neurology Devices, United Arab Emirates, Overall Revenue ($m), USD Constant, Historic, 2004-2011
  • Table 3: Neurology Devices, United Arab Emirates, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
  • Table 4: Neurology Devices, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 5: CSF Management, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 6: CSF Management, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Table 7: CSF Management, United Arab Emirates, Volume (Units) by Segment, Historic, 2004-2011
  • Table 8: CSF Management, United Arab Emirates, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 9: CSF Management, United Arab Emirates, Average Price ($), Historic, 2004-2011
  • Table 10: CSF Management, United Arab Emirates, Average Price ($), Forecast, 2011-2018
  • Table 11: CSF Management, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 12: CSF Management, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 13: Interventional Neurology, United Arab Emirates, Revenue ($m*) USD Constant, by Segment, Historic, 2004-2011
  • Table 14: Interventional Neurology, United Arab Emirates, Revenue ($m*) USD Constant, by Segment, Forecast, 2011-2018
  • Table 15: Embolic Systems, United Arab Emirates, Revenue ($m*) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 16: Embolic Systems, United Arab Emirates, Revenue ($m*) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 17: Navigational Systems, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 18: Navigational Systems, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 19: Interventional Neurology, United Arab Emirates, Volume (Units) by Segment, Historic, 2004-2011
  • Table 20: Interventional Neurology, United Arab Emirates, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 21: Embolic Systems, United Arab Emirates, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 22: Embolic Systems, United Arab Emirates, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 23: Navigational Systems, United Arab Emirates, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 24: Navigational Systems, United Arab Emirates, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 25: Interventional Neurology, United Arab Emirates, Average Price ($), Historic, 2004-2011
  • Table 26: Interventional Neurology, United Arab Emirates, Average Price ($), Forecast, 2011-2018
  • Table 27: Interventional Neurology, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 28: Interventional Neurology, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 29: Neurological Diagnostic Equipment, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 30: Neurological Diagnostic Equipment, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Table 31: Neurological Diagnostic Equipment, United Arab Emirates, Volume (Units) by Segment, Historic, 2004-2011
  • Table 32: Neurological Diagnostic Equipment, United Arab Emirates, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 33: Neurological Diagnostic Equipment, United Arab Emirates, Average Price ($), Historic, 2004-2011
  • Table 34: Neurological Diagnostic Equipment, United Arab Emirates, Average Price ($), Forecast, 2011-2018
  • Table 35: Neurological Diagnostic Equipment, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 36: Neurological Diagnostic Equipment, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 37: Neurostimulation Devices, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 38: Neurostimulation Devices, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Table 39: Neurostimulation Devices, United Arab Emirates, Volume (Units) by Segment, Historic, 2004-2011
  • Table 40: Neurostimulation Devices, United Arab Emirates, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 41: Neurostimulation Devices, United Arab Emirates, Average Price ($), Historic, 2004-2011
  • Table 42: Neurostimulation Devices, United Arab Emirates, Average Price ($), Forecast, 2011-2018
  • Table 43: Neurostimulation Devices, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 44: Neurostimulation Devices, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 45: Neurosurgical Products, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 46: Neurosurgical Products, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Table 47: Neurosurgical Products, United Arab Emirates, Volume (Units) by Segment, Historic, 2004-2011
  • Table 48: Neurosurgical Products, United Arab Emirates, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 49: Neurosurgical Products, United Arab Emirates, Average Price ($), Historic, 2004-2011
  • Table 50: Neurosurgical Products, United Arab Emirates, Average Price ($), Forecast, 2011-2018
  • Table 51: Neurosurgical Products, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 52: Neurosurgical Products, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011

List of Figures

  • Figure 1: Neurology Devices, United Arab Emirates, Overall Revenue ($m), USD Constant, 2004-2018
  • Figure 2: Neurology Devices, United Arab Emirates, Overall Revenue ($m), USD Constant, Historic, 2004-2011
  • Figure 3: Neurology Devices, United Arab Emirates, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
  • Figure 4: Neurology Devices, United Arab Emirates, Company Share (%), 2011
  • Figure 5: CSF Management, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 6: CSF Management, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 7: CSF Management, United Arab Emirates, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 8: CSF Management, United Arab Emirates, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 9: CSF Management, United Arab Emirates, Company Share (%), 2011
  • Figure 10: Interventional Neurology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 11: Interventional Neurology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 12: Embolic Systems, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 13: Embolic Systems, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 14: Navigational Systems, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 15: Navigational Systems, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 16: Interventional Neurology, United Arab Emirates, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 17: Interventional Neurology, United Arab Emirates, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 18: Embolic Systems, United Arab Emirates, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 19: Embolic Systems, United Arab Emirates, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 20: Navigational Systems, United Arab Emirates, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 21: Navigational Systems, United Arab Emirates, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 22: Interventional Neurology, United Arab Emirates, Company Share (%), 2011
  • Figure 23: Neurological Diagnostic Equipment, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 24: Neurological Diagnostic Equipment, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 25: Neurological Diagnostic Equipment, United Arab Emirates, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 26: Neurological Diagnostic Equipment, United Arab Emirates, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 27: Neurological Diagnostic Equipment, United Arab Emirates, Company Share (%), 2011
  • Figure 28: Neurostimulation Devices, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 29: Neurostimulation Devices, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 30: Neurostimulation Devices, United Arab Emirates, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 31: Neurostimulation Devices, United Arab Emirates, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 32: Neurostimulation Devices, United Arab Emirates, Company Share (%), 2011
  • Figure 33: Neurosurgical Products, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 34: Neurosurgical Products, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 35: Neurosurgical Products, United Arab Emirates, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 36: Neurosurgical Products, United Arab Emirates, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 37: Neurosurgical Products, United Arab Emirates, Company Share (%), 2011
  • Figure 38: Global Markets Direct Methodology
Back to Top